TUDOR INVESTMENT CORP ET AL - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 319 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$241,514
+15312.5%
7,638
-83.0%
0.00%
-93.5%
Q4 2022$1,567
-99.9%
44,902
+44.4%
0.03%
-18.4%
Q3 2022$1,740,000
+24.2%
31,085
+61.3%
0.04%
+15.2%
Q1 2022$1,401,000
-13.7%
19,273
+59.2%
0.03%
+26.9%
Q3 2021$1,624,000
+34.5%
12,109
+62.4%
0.03%
+13.0%
Q2 2021$1,207,0007,4550.02%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders